Laura Orton
Director of Operations
Laura oversees the day-to-day operations at Total Delivery Pharma, helping to keep the business organised, efficient, and moving in the right direction. Her role supports TDP’s technical team by making sure the right processes, systems, and internal structure are in place behind the scenes.
With a background in supporting startups and growing businesses, Laura brings a practical, commercially aware approach to operations. She understands what fast-moving businesses need at different stages of growth and helps translate that into clear ways of working.
Her remit covers project coordination, internal processes, systems, team communication, and the general problem-solving that comes with working in a growing consultancy. She works closely with Thomas, TDP’s Founder and Managing Director, providing operational support across the business as it continues to develop.
Laura is proactive, detail-focused, and quick to spot where improvements can be made before they become bigger issues. For TDP’s clients, that means working with a consultancy that is not only technically strong, but also well-run, responsive, and straightforward to engage with.
Latest Work
Expanding into new markets without a dedicated regulatory affairs team is the reality for many pharma companies. Here is how to build and manage a global submission programme that holds up under agency scrutiny — from pathway strategy and dossier architecture to post-submission management.
Scale-up failures don't just delay manufacturing. They delay regulatory approval. Learn how proactive MS&T input protects your programme and strengthens your CMC package.
Most regulatory submission delays trace back to CMC. Understand the most common gaps, why they happen, and how to prevent them before your filing reaches the agency.
Need specialist CMC expertise but cannot justify permanent headcount? Learn how outsourced CMC models give growing pharmaceutical companies the capability they need, at the stages they need it most.
Outsourcing regulatory affairs is not always the right call. But for many pharma businesses, it is. Here is how to know when the case stacks up
No quality team? No problem. Learn how scaling pharma companies build compliant, investor-ready quality functions without permanent headcount. Practical guidance from TDP.
No in-house audit team? Learn how to structure compliant GxP audit coverage using outsourced and retained models. Practical guidance for pharmaceutical and biotech organisations.
TDP's key takeaways from Making & Distributing Pharma 2026. What the MHRA said about AI governance, Annex 22, decentralised medicines, and the landmark transparency
Need a fast regulatory answer without starting a full project? TDP's Just Ask service gives you direct access to senior expertise within 24-48 hours. Find out how.
Received an inspection finding from the MHRA or FDA? Learn how to triage, structure a credible CAPA response, and protect your programme timeline. Expert guidance from TDP.
Total Delivery Pharma (TDP) announces a collaboration with Doc Check AI to explore AI-driven automation for GMP/GDP documentation and compliant document workflows.
Inside the TDP logo: a modern pharmacy “+”, an arterial droplet, and authoritative typography designed to signal GMP/GDP rigour and end-to-end delivery.
UK and EU healthcare regulations are diverging post-Brexit, requiring companies to navigate two evolving systems while maintaining compliance across both.
What GDP means in practice, why MHRA inspects it, where findings happen, and how to stay inspection-ready under a WDA(H).
Learn what a Responsible Person (RP) is, when you need one, what they do under GDP, how they differ from an RPi/QP, and how to appoint the right RP.
Learn what a Qualified Person (QP) does, when one is required, and how QP certification works under EU & UK GMP. Practical guidance from TDP.